

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 9.28858373 |
| 2 | aggressive behavior (GO:0002118) | 8.37486286 |
| 3 | definitive hemopoiesis (GO:0060216) | 8.09828226 |
| 4 | positive regulation of amino acid transport (GO:0051957) | 7.64551447 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.39805802 |
| 6 | female mating behavior (GO:0060180) | 7.31815856 |
| 7 | regulation of female receptivity (GO:0045924) | 7.25386367 |
| 8 | protein kinase C signaling (GO:0070528) | 7.24424044 |
| 9 | viral transcription (GO:0019083) | 6.68878485 |
| 10 | platelet dense granule organization (GO:0060155) | 6.59429223 |
| 11 | antigen processing and presentation via MHC class Ib (GO:0002475) | 6.54021180 |
| 12 | translational termination (GO:0006415) | 6.31148126 |
| 13 | hyperosmotic salinity response (GO:0042538) | 6.21677440 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.97045911 |
| 15 | response to interferon-beta (GO:0035456) | 5.75284477 |
| 16 | positive regulation of systemic arterial blood pressure (GO:0003084) | 5.72827964 |
| 17 | maturation of SSU-rRNA (GO:0030490) | 5.65286697 |
| 18 | regulation of glutamate secretion (GO:0014048) | 5.64779097 |
| 19 | regulation of transmission of nerve impulse (GO:0051969) | 5.46997714 |
| 20 | ribosomal small subunit biogenesis (GO:0042274) | 5.46359421 |
| 21 | grooming behavior (GO:0007625) | 5.42159705 |
| 22 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.41979939 |
| 23 | response to interferon-alpha (GO:0035455) | 5.36106278 |
| 24 | translational elongation (GO:0006414) | 5.35299190 |
| 25 | cotranslational protein targeting to membrane (GO:0006613) | 5.31263450 |
| 26 | protein targeting to ER (GO:0045047) | 5.28110655 |
| 27 | regulation of cellular extravasation (GO:0002691) | 5.16946131 |
| 28 | protein localization to endoplasmic reticulum (GO:0070972) | 5.06201674 |
| 29 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.02239719 |
| 30 | viral life cycle (GO:0019058) | 4.83619528 |
| 31 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.83393837 |
| 32 | megakaryocyte development (GO:0035855) | 4.78621102 |
| 33 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.75591048 |
| 34 | maternal behavior (GO:0042711) | 4.71894990 |
| 35 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.63178710 |
| 36 | endothelium development (GO:0003158) | 4.55971574 |
| 37 | cellular protein complex disassembly (GO:0043624) | 4.52033204 |
| 38 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.41966710 |
| 39 | lymphoid progenitor cell differentiation (GO:0002320) | 4.36109149 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.30090708 |
| 41 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.30090708 |
| 42 | endosome to melanosome transport (GO:0035646) | 4.29642220 |
| 43 | endosome to pigment granule transport (GO:0043485) | 4.29642220 |
| 44 | hyperosmotic response (GO:0006972) | 4.27213995 |
| 45 | secretory granule organization (GO:0033363) | 4.25185806 |
| 46 | parental behavior (GO:0060746) | 4.23092690 |
| 47 | phospholipid scrambling (GO:0017121) | 4.22724803 |
| 48 | DNA deamination (GO:0045006) | 4.20481242 |
| 49 | positive regulation of organic acid transport (GO:0032892) | 4.16085016 |
| 50 | heparin biosynthetic process (GO:0030210) | 4.11895012 |
| 51 | heparin metabolic process (GO:0030202) | 4.11895012 |
| 52 | protein complex disassembly (GO:0043241) | 4.10160725 |
| 53 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.09314314 |
| 54 | * mature B cell differentiation involved in immune response (GO:0002313) | 4.09197999 |
| 55 | translational initiation (GO:0006413) | 4.09053660 |
| 56 | negative regulation of B cell apoptotic process (GO:0002903) | 4.00949449 |
| 57 | base-excision repair, AP site formation (GO:0006285) | 3.99335426 |
| 58 | regulation of antigen processing and presentation (GO:0002577) | 3.96271479 |
| 59 | positive regulation of antigen processing and presentation (GO:0002579) | 3.94964668 |
| 60 | negative regulation of viral entry into host cell (GO:0046597) | 3.93692969 |
| 61 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.91768119 |
| 62 | regulation of respiratory burst (GO:0060263) | 3.88941985 |
| 63 | * lymph node development (GO:0048535) | 3.88411067 |
| 64 | L-fucose catabolic process (GO:0042355) | 3.85805638 |
| 65 | fucose catabolic process (GO:0019317) | 3.85805638 |
| 66 | L-fucose metabolic process (GO:0042354) | 3.85805638 |
| 67 | macromolecular complex disassembly (GO:0032984) | 3.77086135 |
| 68 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.74297182 |
| 69 | cellular hyperosmotic response (GO:0071474) | 3.73979216 |
| 70 | negative regulation of viral genome replication (GO:0045071) | 3.73113046 |
| 71 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.73037297 |
| 72 | positive regulation of catecholamine secretion (GO:0033605) | 3.71772992 |
| 73 | positive regulation of B cell differentiation (GO:0045579) | 3.64588319 |
| 74 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.62744024 |
| 75 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.62744024 |
| 76 | mRNA catabolic process (GO:0006402) | 3.61113988 |
| 77 | angiotensin maturation (GO:0002003) | 3.59818136 |
| 78 | sodium-independent organic anion transport (GO:0043252) | 3.59518804 |
| 79 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.57220590 |
| 80 | defense response to protozoan (GO:0042832) | 3.56844422 |
| 81 | regulation of regulatory T cell differentiation (GO:0045589) | 3.56754691 |
| 82 | T-helper 1 type immune response (GO:0042088) | 3.56149578 |
| 83 | regulation of erythrocyte differentiation (GO:0045646) | 3.55886634 |
| 84 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.54545985 |
| 85 | seminiferous tubule development (GO:0072520) | 3.54053968 |
| 86 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.53581933 |
| 87 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.51968323 |
| 88 | deoxyribonucleotide catabolic process (GO:0009264) | 3.51654590 |
| 89 | protein targeting to membrane (GO:0006612) | 3.50392186 |
| 90 | response to protozoan (GO:0001562) | 3.49716415 |
| 91 | regulation of RIG-I signaling pathway (GO:0039535) | 3.44386337 |
| 92 | positive regulation of respiratory burst (GO:0060267) | 3.42214786 |
| 93 | type I interferon signaling pathway (GO:0060337) | 3.41360080 |
| 94 | cellular response to type I interferon (GO:0071357) | 3.41360080 |
| 95 | positive regulation of prostaglandin secretion (GO:0032308) | 3.38993331 |
| 96 | response to type I interferon (GO:0034340) | 3.37129979 |
| 97 | ERK1 and ERK2 cascade (GO:0070371) | 3.36870287 |
| 98 | RNA catabolic process (GO:0006401) | 3.36220592 |
| 99 | polyketide metabolic process (GO:0030638) | 3.31681396 |
| 100 | doxorubicin metabolic process (GO:0044598) | 3.31681396 |
| 101 | daunorubicin metabolic process (GO:0044597) | 3.31681396 |
| 102 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.30163676 |
| 103 | facial nerve structural organization (GO:0021612) | 3.26863841 |
| 104 | T cell homeostasis (GO:0043029) | 3.26811313 |
| 105 | mannose metabolic process (GO:0006013) | 3.26118896 |
| 106 | deoxyribose phosphate catabolic process (GO:0046386) | 3.25662989 |
| 107 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.25431433 |
| 108 | embryonic hemopoiesis (GO:0035162) | 3.24044251 |
| 109 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.22995697 |
| 110 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.21970787 |
| 111 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.20257869 |
| 112 | regulation of natural killer cell differentiation (GO:0032823) | 3.17598521 |
| 113 | purine-containing compound salvage (GO:0043101) | 3.12803592 |
| 114 | serotonin receptor signaling pathway (GO:0007210) | 3.11121309 |
| 115 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.10258561 |
| 116 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.10046505 |
| 117 | cGMP biosynthetic process (GO:0006182) | 3.09943514 |
| 118 | positive regulation of amine transport (GO:0051954) | 3.08409222 |
| 119 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.04530417 |
| 120 | regulation of necrotic cell death (GO:0010939) | 3.03541546 |
| 121 | positive regulation of neutrophil migration (GO:1902624) | 3.03249691 |
| 122 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.03249691 |
| 123 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.01899518 |
| 124 | cellular response to interferon-beta (GO:0035458) | 3.01066276 |
| 125 | cell differentiation involved in metanephros development (GO:0072202) | 2.99046310 |
| 126 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.97796556 |
| 127 | positive regulation of granulocyte differentiation (GO:0030854) | 2.94422436 |
| 128 | regulation of viral entry into host cell (GO:0046596) | 2.93620261 |
| 129 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.92544527 |
| 130 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.91088916 |
| 131 | glomerular filtration (GO:0003094) | 2.90097844 |
| 132 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.89606477 |
| 133 | * mature B cell differentiation (GO:0002335) | 2.89403237 |
| 134 | myeloid dendritic cell activation (GO:0001773) | 2.87598904 |
| 135 | execution phase of apoptosis (GO:0097194) | 2.86540630 |
| 136 | necroptotic process (GO:0070266) | 2.85980527 |
| 137 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.85807422 |
| 138 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.85309628 |
| 139 | ribosomal large subunit biogenesis (GO:0042273) | 2.85117193 |
| 140 | pinocytosis (GO:0006907) | 2.84890248 |
| 141 | respiratory tube development (GO:0030323) | 2.84528680 |
| 142 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.84244231 |
| 143 | negative regulation of granulocyte differentiation (GO:0030853) | 2.83686792 |
| 144 | regulation of gamma-delta T cell activation (GO:0046643) | 2.82288092 |
| 145 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.81525593 |
| 146 | deoxyribose phosphate metabolic process (GO:0019692) | 2.81279570 |
| 147 | type B pancreatic cell proliferation (GO:0044342) | 2.81179212 |
| 148 | thrombin receptor signaling pathway (GO:0070493) | 2.80971120 |
| 149 | granulocyte differentiation (GO:0030851) | 2.80664401 |
| 150 | fucosylation (GO:0036065) | 2.80459316 |
| 151 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.79358883 |
| 152 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.77578384 |
| 153 | regulation of B cell differentiation (GO:0045577) | 2.77313162 |
| 154 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.76369379 |
| 155 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.75702129 |
| 156 | multicellular organismal reproductive behavior (GO:0033057) | 2.74056175 |
| 157 | regulation of amino acid transport (GO:0051955) | 2.73480190 |
| 158 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.72761941 |
| 159 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.72115321 |
| 160 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.70737946 |
| 161 | response to interleukin-15 (GO:0070672) | 2.70413805 |
| 162 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.70149434 |
| 163 | positive regulation of blood pressure (GO:0045777) | 2.69850351 |
| 164 | regulation of response to osmotic stress (GO:0047484) | 2.67825988 |
| 165 | toxin transport (GO:1901998) | 2.67680288 |
| 166 | negative regulation of leukocyte migration (GO:0002686) | 2.67593556 |
| 167 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.67128095 |
| 168 | blood vessel maturation (GO:0001955) | 2.66741235 |
| 169 | detection of bacterium (GO:0016045) | 2.66653362 |
| 170 | dosage compensation (GO:0007549) | 2.66594119 |
| 171 | regulation of prostaglandin secretion (GO:0032306) | 2.66587364 |
| 172 | regulation of necroptotic process (GO:0060544) | 2.65759609 |
| 173 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.65608541 |
| 174 | translation (GO:0006412) | 2.64898201 |
| 175 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.64741302 |
| 176 | immunoglobulin mediated immune response (GO:0016064) | 2.64635077 |
| 177 | regulation of guanylate cyclase activity (GO:0031282) | 2.64606470 |
| 178 | antibacterial humoral response (GO:0019731) | 2.64503717 |
| 179 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.64185489 |
| 180 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.64002708 |
| 181 | regulation of viral genome replication (GO:0045069) | 2.63743241 |
| 182 | cellular response to exogenous dsRNA (GO:0071360) | 2.63704210 |
| 183 | phagocytosis, engulfment (GO:0006911) | 2.60892979 |
| 184 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.60194984 |
| 185 | regulation of histone phosphorylation (GO:0033127) | 2.60014211 |
| 186 | negative regulation of neurological system process (GO:0031645) | 2.59325777 |
| 187 | B cell mediated immunity (GO:0019724) | 2.58493988 |
| 188 | regulation of B cell apoptotic process (GO:0002902) | 2.57225028 |
| 189 | NIK/NF-kappaB signaling (GO:0038061) | 2.55512178 |
| 190 | antimicrobial humoral response (GO:0019730) | 2.55505823 |
| 191 | vasoconstriction (GO:0042310) | 2.51988259 |
| 192 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.50903972 |
| 193 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.48332279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 5.88987999 |
| 2 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 4.16759960 |
| 3 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.74654228 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.73131130 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.69402670 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.52800940 |
| 7 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.29474395 |
| 8 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.20946156 |
| 9 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.15934293 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.94929650 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.90809144 |
| 12 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.84624059 |
| 13 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.73875370 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.68507461 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.66654051 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.60969453 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.60345095 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.57557518 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.56932453 |
| 20 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.55415293 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41593179 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.40319629 |
| 23 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35243631 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.34166202 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.29579545 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.28474189 |
| 27 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.23714430 |
| 28 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.15487316 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.11045499 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07711980 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05444333 |
| 32 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.04150629 |
| 33 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.00393995 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.97273819 |
| 35 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.96047681 |
| 36 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92310647 |
| 37 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.90876886 |
| 38 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.87993726 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.84976582 |
| 40 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.81748329 |
| 41 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.77709918 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70292586 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.69881047 |
| 44 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.67225402 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64241248 |
| 46 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.64006182 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.63401871 |
| 48 | P68_20966046_ChIP-Seq_HELA_Human | 1.61176108 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60462877 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.59883242 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59777727 |
| 52 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.58603312 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.56785580 |
| 54 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.54316742 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.53784970 |
| 56 | MYB_26560356_Chip-Seq_TH2_Human | 1.53363117 |
| 57 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.50687444 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.49925274 |
| 59 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.49204223 |
| 60 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.49192082 |
| 61 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.46927563 |
| 62 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45878326 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.45190133 |
| 64 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.44510209 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.44329690 |
| 66 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.44300327 |
| 67 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.42934051 |
| 68 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40913350 |
| 69 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.40639605 |
| 70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40621040 |
| 71 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40573226 |
| 72 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40332239 |
| 73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40217470 |
| 74 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39019466 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38610245 |
| 76 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37217706 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36853599 |
| 78 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.36062384 |
| 79 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35628856 |
| 80 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.35260834 |
| 81 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.32583236 |
| 82 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.32538100 |
| 83 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.30043919 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29583665 |
| 85 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.28591442 |
| 86 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.28377987 |
| 87 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.27064573 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.26934986 |
| 89 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25309867 |
| 90 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.24076200 |
| 91 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23206369 |
| 92 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22711722 |
| 93 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.22701586 |
| 94 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22670751 |
| 95 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21186508 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20674164 |
| 97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20258409 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19594883 |
| 99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.19593621 |
| 100 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.19124126 |
| 101 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19049528 |
| 102 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.18709320 |
| 103 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18515208 |
| 104 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.17479090 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17195167 |
| 106 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17076197 |
| 107 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16966957 |
| 108 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16483774 |
| 109 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16430985 |
| 110 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15097958 |
| 111 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.13103768 |
| 112 | MAF_26560356_Chip-Seq_TH2_Human | 1.11737843 |
| 113 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.11681058 |
| 114 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11432409 |
| 115 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.09671614 |
| 116 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09149448 |
| 117 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.08285325 |
| 118 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07554313 |
| 119 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07410800 |
| 120 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07287118 |
| 121 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.06567216 |
| 122 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06421175 |
| 123 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06132498 |
| 124 | P300_27268052_Chip-Seq_Bcells_Human | 1.04705060 |
| 125 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03288211 |
| 126 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.03187988 |
| 127 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02617434 |
| 128 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02487988 |
| 129 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02095246 |
| 130 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01491172 |
| 131 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.00897584 |
| 132 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00405218 |
| 133 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99925507 |
| 134 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.99204184 |
| 135 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.98834873 |
| 136 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98318327 |
| 137 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.96776553 |
| 138 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.95474739 |
| 139 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.91752229 |
| 140 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84333746 |
| 141 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.81480680 |
| 142 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80272653 |
| 143 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.78620863 |
| 144 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.78277892 |
| 145 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.78092425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.90684098 |
| 2 | MP0005645_abnormal_hypothalamus_physiol | 3.90643448 |
| 3 | MP0004808_abnormal_hematopoietic_stem | 3.87884845 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.86578345 |
| 5 | MP0000685_abnormal_immune_system | 3.67411284 |
| 6 | MP0009785_altered_susceptibility_to | 3.17922904 |
| 7 | MP0010368_abnormal_lymphatic_system | 3.15453533 |
| 8 | MP0005397_hematopoietic_system_phenotyp | 3.12640256 |
| 9 | MP0001545_abnormal_hematopoietic_system | 3.12640256 |
| 10 | MP0001835_abnormal_antigen_presentation | 3.12121606 |
| 11 | MP0005174_abnormal_tail_pigmentation | 2.89996163 |
| 12 | MP0000465_gastrointestinal_hemorrhage | 2.86606991 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.83135293 |
| 14 | MP0005671_abnormal_response_to | 2.82390695 |
| 15 | MP0009379_abnormal_foot_pigmentation | 2.73213174 |
| 16 | MP0005075_abnormal_melanosome_morpholog | 2.55020122 |
| 17 | MP0005025_abnormal_response_to | 2.48848360 |
| 18 | MP0010155_abnormal_intestine_physiology | 2.22018196 |
| 19 | MP0001853_heart_inflammation | 2.14316831 |
| 20 | MP0002398_abnormal_bone_marrow | 2.12639609 |
| 21 | MP0009278_abnormal_bone_marrow | 2.08421710 |
| 22 | MP0003183_abnormal_peptide_metabolism | 2.05728987 |
| 23 | MP0001800_abnormal_humoral_immune | 2.04018718 |
| 24 | MP0002822_catalepsy | 2.03810420 |
| 25 | MP0004782_abnormal_surfactant_physiolog | 1.99820897 |
| 26 | MP0002095_abnormal_skin_pigmentation | 1.98836247 |
| 27 | MP0002723_abnormal_immune_serum | 1.96642845 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.94915378 |
| 29 | * MP0000689_abnormal_spleen_morphology | 1.90696254 |
| 30 | MP0003943_abnormal_hepatobiliary_system | 1.90426281 |
| 31 | * MP0001664_abnormal_digestion | 1.88082974 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.83365361 |
| 33 | MP0005360_urolithiasis | 1.82923263 |
| 34 | * MP0002420_abnormal_adaptive_immunity | 1.82246782 |
| 35 | * MP0001819_abnormal_immune_cell | 1.80435608 |
| 36 | * MP0002722_abnormal_immune_system | 1.79795560 |
| 37 | MP0003303_peritoneal_inflammation | 1.76383607 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.74287522 |
| 39 | MP0008057_abnormal_DNA_replication | 1.73045156 |
| 40 | * MP0000716_abnormal_immune_system | 1.70722974 |
| 41 | * MP0003866_abnormal_defecation | 1.69830251 |
| 42 | MP0003724_increased_susceptibility_to | 1.69732881 |
| 43 | * MP0000490_abnormal_crypts_of | 1.67691722 |
| 44 | MP0008961_abnormal_basal_metabolism | 1.65561944 |
| 45 | MP0005166_decreased_susceptibility_to | 1.65333870 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.65178193 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.64186938 |
| 48 | * MP0002429_abnormal_blood_cell | 1.61975579 |
| 49 | MP0003436_decreased_susceptibility_to | 1.61437312 |
| 50 | MP0001790_abnormal_immune_system | 1.59737080 |
| 51 | MP0005387_immune_system_phenotype | 1.59737080 |
| 52 | MP0004147_increased_porphyrin_level | 1.56707842 |
| 53 | MP0003279_aneurysm | 1.55860998 |
| 54 | MP0005085_abnormal_gallbladder_physiolo | 1.54623731 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.51777675 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.50301887 |
| 57 | MP0002419_abnormal_innate_immunity | 1.49578565 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.46803144 |
| 59 | MP0005409_darkened_coat_color | 1.44201244 |
| 60 | MP0008007_abnormal_cellular_replicative | 1.41348447 |
| 61 | MP0001879_abnormal_lymphatic_vessel | 1.37796003 |
| 62 | MP0001188_hyperpigmentation | 1.36926313 |
| 63 | MP0001873_stomach_inflammation | 1.36032118 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.30779112 |
| 65 | MP0000703_abnormal_thymus_morphology | 1.30511034 |
| 66 | MP0001764_abnormal_homeostasis | 1.27985610 |
| 67 | MP0000462_abnormal_digestive_system | 1.27868836 |
| 68 | MP0002166_altered_tumor_susceptibility | 1.26861131 |
| 69 | MP0000681_abnormal_thyroid_gland | 1.24758530 |
| 70 | MP0003828_pulmonary_edema | 1.21947083 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.20941098 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 1.20033094 |
| 73 | MP0010386_abnormal_urinary_bladder | 1.18679817 |
| 74 | MP0006292_abnormal_olfactory_placode | 1.18336616 |
| 75 | MP0008058_abnormal_DNA_repair | 1.16219835 |
| 76 | MP0002132_abnormal_respiratory_system | 1.15788742 |
| 77 | MP0006054_spinal_hemorrhage | 1.14785504 |
| 78 | MP0000013_abnormal_adipose_tissue | 1.12417082 |
| 79 | MP0003315_abnormal_perineum_morphology | 1.09650672 |
| 80 | MP0005595_abnormal_vascular_smooth | 1.08129865 |
| 81 | MP0009384_cardiac_valve_regurgitation | 1.08012020 |
| 82 | MP0003300_gastrointestinal_ulcer | 1.07828899 |
| 83 | MP0005381_digestive/alimentary_phenotyp | 1.07584978 |
| 84 | MP0002405_respiratory_system_inflammati | 1.03794346 |
| 85 | MP0000516_abnormal_urinary_system | 1.03027801 |
| 86 | MP0005367_renal/urinary_system_phenotyp | 1.03027801 |
| 87 | MP0008469_abnormal_protein_level | 1.00878568 |
| 88 | MP0002928_abnormal_bile_duct | 0.99406471 |
| 89 | MP0004185_abnormal_adipocyte_glucose | 0.99005709 |
| 90 | MP0004858_abnormal_nervous_system | 0.95308642 |
| 91 | MP0003567_abnormal_fetal_cardiomyocyte | 0.94645900 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.93277105 |
| 93 | MP0003075_altered_response_to | 0.93256176 |
| 94 | MP0002019_abnormal_tumor_incidence | 0.90438885 |
| 95 | MP0002938_white_spotting | 0.89589795 |
| 96 | MP0004264_abnormal_extraembryonic_tissu | 0.88891742 |
| 97 | * MP0001666_abnormal_nutrient_absorption | 0.88634391 |
| 98 | MP0000313_abnormal_cell_death | 0.87977213 |
| 99 | MP0005390_skeleton_phenotype | 0.87739627 |
| 100 | * MP0000477_abnormal_intestine_morphology | 0.86106591 |
| 101 | MP0004947_skin_inflammation | 0.85453041 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.84197330 |
| 103 | MP0008775_abnormal_heart_ventricle | 0.84193181 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.83956506 |
| 105 | MP0000249_abnormal_blood_vessel | 0.83351712 |
| 106 | MP0002735_abnormal_chemical_nociception | 0.83335434 |
| 107 | MP0001881_abnormal_mammary_gland | 0.82403550 |
| 108 | MP0009697_abnormal_copulation | 0.82351247 |
| 109 | MP0000538_abnormal_urinary_bladder | 0.82057944 |
| 110 | MP0009840_abnormal_foam_cell | 0.81049331 |
| 111 | MP0003693_abnormal_embryo_hatching | 0.81020860 |
| 112 | MP0004510_myositis | 0.80006173 |
| 113 | MP0000678_abnormal_parathyroid_gland | 0.79941498 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.79562126 |
| 115 | MP0003123_paternal_imprinting | 0.79166871 |
| 116 | MP0002006_tumorigenesis | 0.79044021 |
| 117 | MP0001663_abnormal_digestive_system | 0.78849555 |
| 118 | MP0005084_abnormal_gallbladder_morpholo | 0.78069987 |
| 119 | MP0000858_altered_metastatic_potential | 0.77757216 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.76648352 |
| 121 | MP0000534_abnormal_ureter_morphology | 0.75219419 |
| 122 | MP0009643_abnormal_urine_homeostasis | 0.73910738 |
| 123 | MP0009764_decreased_sensitivity_to | 0.73742518 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.73418195 |
| 125 | MP0000343_altered_response_to | 0.73060379 |
| 126 | * MP0000613_abnormal_salivary_gland | 0.72444080 |
| 127 | MP0005376_homeostasis/metabolism_phenot | 0.71505201 |
| 128 | MP0005332_abnormal_amino_acid | 0.71321882 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.69407133 |
| 130 | MP0000015_abnormal_ear_pigmentation | 0.67905718 |
| 131 | MP0002089_abnormal_postnatal_growth/wei | 0.67429669 |
| 132 | MP0003122_maternal_imprinting | 0.67224977 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.67169630 |
| 134 | MP0009763_increased_sensitivity_to | 0.66919536 |
| 135 | MP0002139_abnormal_hepatobiliary_system | 0.64248635 |
| 136 | MP0000372_irregular_coat_pigmentation | 0.63783860 |
| 137 | MP0002138_abnormal_hepatobiliary_system | 0.62421905 |
| 138 | MP0002249_abnormal_larynx_morphology | 0.62403731 |
| 139 | MP0002075_abnormal_coat/hair_pigmentati | 0.61278499 |
| 140 | MP0000598_abnormal_liver_morphology | 0.60959393 |
| 141 | MP0008875_abnormal_xenobiotic_pharmacok | 0.60377777 |
| 142 | MP0002933_joint_inflammation | 0.60290518 |
| 143 | MP0000470_abnormal_stomach_morphology | 0.59685766 |
| 144 | MP0001191_abnormal_skin_condition | 0.57521569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 6.78865332 |
| 2 | Aplastic anemia (HP:0001915) | 6.00376542 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.49535025 |
| 4 | Abnormal number of erythroid precursors (HP:0012131) | 5.25085097 |
| 5 | Prolonged bleeding time (HP:0003010) | 4.97000303 |
| 6 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.21902345 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.06824128 |
| 8 | Abnormality of the fetal cardiovascular system (HP:0010948) | 3.98084651 |
| 9 | Abnormal umbilical cord blood vessels (HP:0011403) | 3.98084651 |
| 10 | Single umbilical artery (HP:0001195) | 3.98084651 |
| 11 | Muscle fiber atrophy (HP:0100295) | 3.97637901 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 3.95030740 |
| 13 | Epistaxis (HP:0000421) | 3.92062845 |
| 14 | Type 2 muscle fiber atrophy (HP:0003554) | 3.90984771 |
| 15 | IgM deficiency (HP:0002850) | 3.85042664 |
| 16 | Nonprogressive disorder (HP:0003680) | 3.83294304 |
| 17 | Myositis (HP:0100614) | 3.71230854 |
| 18 | Reticulocytopenia (HP:0001896) | 3.69091853 |
| 19 | Chronic otitis media (HP:0000389) | 3.64328284 |
| 20 | Asplenia (HP:0001746) | 3.41094040 |
| 21 | Abnormal platelet function (HP:0011869) | 3.36940993 |
| 22 | Impaired platelet aggregation (HP:0003540) | 3.36940993 |
| 23 | Pallor (HP:0000980) | 3.36829702 |
| 24 | Petechiae (HP:0000967) | 3.27101547 |
| 25 | Reduced antithrombin III activity (HP:0001976) | 3.23283507 |
| 26 | Amaurosis fugax (HP:0100576) | 3.18752658 |
| 27 | Abnormality of B cell number (HP:0010975) | 3.18504387 |
| 28 | Metaphyseal dysplasia (HP:0100255) | 3.12290993 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.08754061 |
| 30 | Acute lymphatic leukemia (HP:0006721) | 3.06487611 |
| 31 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 3.05445169 |
| 32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.01936213 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 3.01936213 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.01936213 |
| 35 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.95871145 |
| 36 | Hyperglycinemia (HP:0002154) | 2.93463708 |
| 37 | Spontaneous hematomas (HP:0007420) | 2.92077160 |
| 38 | Abnormality of the nasal mucosa (HP:0000433) | 2.86492062 |
| 39 | Weak cry (HP:0001612) | 2.85729526 |
| 40 | Myelodysplasia (HP:0002863) | 2.83863237 |
| 41 | Abnormality of the umbilical cord (HP:0010881) | 2.83220760 |
| 42 | Neonatal hypoglycemia (HP:0001998) | 2.77860652 |
| 43 | Microcytic anemia (HP:0001935) | 2.76198732 |
| 44 | Macrocytic anemia (HP:0001972) | 2.75088432 |
| 45 | Colon cancer (HP:0003003) | 2.74375078 |
| 46 | Pancytopenia (HP:0001876) | 2.73496830 |
| 47 | Purpura (HP:0000979) | 2.68264607 |
| 48 | Type I transferrin isoform profile (HP:0003642) | 2.67375412 |
| 49 | Aortic aneurysm (HP:0004942) | 2.66092856 |
| 50 | Interstitial pulmonary disease (HP:0006530) | 2.65141922 |
| 51 | Hyperglycinuria (HP:0003108) | 2.64853691 |
| 52 | Hypothermia (HP:0002045) | 2.63357083 |
| 53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.62470828 |
| 54 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.61993270 |
| 55 | Recurrent bronchitis (HP:0002837) | 2.60346821 |
| 56 | Poikiloderma (HP:0001029) | 2.59289197 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 2.59085629 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59085629 |
| 59 | Seborrheic dermatitis (HP:0001051) | 2.58695991 |
| 60 | Atrioventricular block (HP:0001678) | 2.54324626 |
| 61 | Decreased skull ossification (HP:0004331) | 2.53788907 |
| 62 | B lymphocytopenia (HP:0010976) | 2.51120674 |
| 63 | Cellulitis (HP:0100658) | 2.51078070 |
| 64 | Increased IgM level (HP:0003496) | 2.50656789 |
| 65 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.50482042 |
| 66 | Radial bowing (HP:0002986) | 2.46363064 |
| 67 | Patchy hypopigmentation of hair (HP:0011365) | 2.45441169 |
| 68 | Acute myeloid leukemia (HP:0004808) | 2.42243288 |
| 69 | Pustule (HP:0200039) | 2.39479974 |
| 70 | Abnormality of T cell physiology (HP:0011840) | 2.37366335 |
| 71 | Malnutrition (HP:0004395) | 2.36927926 |
| 72 | Myoglobinuria (HP:0002913) | 2.36246150 |
| 73 | Mediastinal lymphadenopathy (HP:0100721) | 2.34008464 |
| 74 | Fatigue (HP:0012378) | 2.32143103 |
| 75 | Cerebral palsy (HP:0100021) | 2.31927410 |
| 76 | Spontaneous abortion (HP:0005268) | 2.30658219 |
| 77 | Pancreatitis (HP:0001733) | 2.29977218 |
| 78 | Ileus (HP:0002595) | 2.29687794 |
| 79 | Gingival bleeding (HP:0000225) | 2.29145581 |
| 80 | Menorrhagia (HP:0000132) | 2.28732821 |
| 81 | Hypertensive crisis (HP:0100735) | 2.27631329 |
| 82 | Agammaglobulinemia (HP:0004432) | 2.27530794 |
| 83 | J-shaped sella turcica (HP:0002680) | 2.27493957 |
| 84 | Chronic obstructive pulmonary disease (HP:0006510) | 2.27325176 |
| 85 | Obstructive lung disease (HP:0006536) | 2.27325176 |
| 86 | Papilledema (HP:0001085) | 2.27159962 |
| 87 | Abnormal protein glycosylation (HP:0012346) | 2.27062913 |
| 88 | Abnormal glycosylation (HP:0012345) | 2.27062913 |
| 89 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.27062913 |
| 90 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.27062913 |
| 91 | White forelock (HP:0002211) | 2.26662649 |
| 92 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.23873976 |
| 93 | Abnormality of skull ossification (HP:0002703) | 2.23508979 |
| 94 | Exertional dyspnea (HP:0002875) | 2.23439190 |
| 95 | Muscle stiffness (HP:0003552) | 2.22588832 |
| 96 | Gastrointestinal dysmotility (HP:0002579) | 2.22484411 |
| 97 | Abnormality of the 1st metacarpal (HP:0010009) | 2.21560708 |
| 98 | Chronic diarrhea (HP:0002028) | 2.21243040 |
| 99 | Hypergammaglobulinemia (HP:0010702) | 2.20695268 |
| 100 | Abnormality of glycine metabolism (HP:0010895) | 2.19871463 |
| 101 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.19871463 |
| 102 | Hydroureter (HP:0000072) | 2.19808421 |
| 103 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.19425245 |
| 104 | Xerostomia (HP:0000217) | 2.18437548 |
| 105 | Migraine (HP:0002076) | 2.16898585 |
| 106 | Aortic dissection (HP:0002647) | 2.16693124 |
| 107 | Neoplasm of the oral cavity (HP:0100649) | 2.16654861 |
| 108 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16225207 |
| 109 | Hypoproteinemia (HP:0003075) | 2.16188711 |
| 110 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.13810027 |
| 111 | Short 1st metacarpal (HP:0010034) | 2.13810027 |
| 112 | Microretrognathia (HP:0000308) | 2.13302451 |
| 113 | Erythema (HP:0010783) | 2.12777854 |
| 114 | Urticaria (HP:0001025) | 2.11968547 |
| 115 | Dysostosis multiplex (HP:0000943) | 2.11476220 |
| 116 | Recurrent fungal infections (HP:0002841) | 2.11374351 |
| 117 | Lipid accumulation in hepatocytes (HP:0006561) | 2.09748940 |
| 118 | Abnormality of the prostate (HP:0008775) | 2.08834893 |
| 119 | Thyroid-stimulating hormone excess (HP:0002925) | 2.08102099 |
| 120 | Bruising susceptibility (HP:0000978) | 2.07902612 |
| 121 | Hepatosplenomegaly (HP:0001433) | 2.06943197 |
| 122 | Progressive inability to walk (HP:0002505) | 2.06518837 |
| 123 | Lymphopenia (HP:0001888) | 2.06013990 |
| 124 | Panhypogammaglobulinemia (HP:0003139) | 2.05382222 |
| 125 | Episodic fever (HP:0001954) | 2.03872089 |
| 126 | Granulocytopenia (HP:0001913) | 2.03864060 |
| 127 | Ragged-red muscle fibers (HP:0003200) | 2.03184370 |
| 128 | Ketosis (HP:0001946) | 2.00186308 |
| 129 | Easy fatigability (HP:0003388) | 1.97300941 |
| 130 | Increased IgE level (HP:0003212) | 1.96680679 |
| 131 | Rhabdomyolysis (HP:0003201) | 1.96086373 |
| 132 | Gastrointestinal stroma tumor (HP:0100723) | 1.96011940 |
| 133 | Chest pain (HP:0100749) | 1.95622689 |
| 134 | Autoimmune thrombocytopenia (HP:0001973) | 1.95349062 |
| 135 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94567467 |
| 136 | Gastrointestinal inflammation (HP:0004386) | 1.94437728 |
| 137 | Recurrent viral infections (HP:0004429) | 1.94265748 |
| 138 | Breech presentation (HP:0001623) | 1.93980660 |
| 139 | IgG deficiency (HP:0004315) | 1.93715597 |
| 140 | Albinism (HP:0001022) | 1.93562656 |
| 141 | Arterial thrombosis (HP:0004420) | 1.93237121 |
| 142 | Visual hallucinations (HP:0002367) | 1.93093236 |
| 143 | Eczematoid dermatitis (HP:0000976) | 1.92494934 |
| 144 | Meningitis (HP:0001287) | 1.91666960 |
| 145 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.91269138 |
| 146 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.90095293 |
| 147 | Increased intramyocellular lipid droplets (HP:0012240) | 1.89297332 |
| 148 | Birth length less than 3rd percentile (HP:0003561) | 1.89050676 |
| 149 | Orchitis (HP:0100796) | 1.88830391 |
| 150 | Syringomyelia (HP:0003396) | 1.88322150 |
| 151 | Spinal cord lesions (HP:0100561) | 1.88322150 |
| 152 | Exercise-induced myalgia (HP:0003738) | 1.87557902 |
| 153 | Growth hormone excess (HP:0000845) | 1.87428208 |
| 154 | Hypertriglyceridemia (HP:0002155) | 1.86838922 |
| 155 | Flat capital femoral epiphysis (HP:0003370) | 1.86185372 |
| 156 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.83912368 |
| 157 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.83912368 |
| 158 | Pigmentary retinal degeneration (HP:0001146) | 1.82767536 |
| 159 | Pili torti (HP:0003777) | 1.82354764 |
| 160 | Nasal polyposis (HP:0100582) | 1.81355099 |
| 161 | Annular pancreas (HP:0001734) | 1.80949990 |
| 162 | Skin rash (HP:0000988) | 1.80239141 |
| 163 | Potter facies (HP:0002009) | 1.79968765 |
| 164 | Facial shape deformation (HP:0011334) | 1.79968765 |
| 165 | Renal Fanconi syndrome (HP:0001994) | 1.79780212 |
| 166 | Cerebral edema (HP:0002181) | 1.79022869 |
| 167 | Esophageal neoplasm (HP:0100751) | 1.78262998 |
| 168 | Neoplasm of head and neck (HP:0012288) | 1.78262998 |
| 169 | Hyperpituitarism (HP:0010514) | 1.78210937 |
| 170 | Neutropenia (HP:0001875) | 1.77819866 |
| 171 | Asymmetric septal hypertrophy (HP:0001670) | 1.77744958 |
| 172 | Abnormality of the parathyroid morphology (HP:0011766) | 1.77234468 |
| 173 | Hepatic necrosis (HP:0002605) | 1.76774768 |
| 174 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.76264720 |
| 175 | Autoimmune hemolytic anemia (HP:0001890) | 1.74353156 |
| 176 | Increased muscle lipid content (HP:0009058) | 1.72913134 |
| 177 | Broad alveolar ridges (HP:0000187) | 1.70392244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.65507287 |
| 2 | SCYL2 | 3.87261684 |
| 3 | STK16 | 3.85799985 |
| 4 | MUSK | 3.48185457 |
| 5 | TIE1 | 3.44954691 |
| 6 | TGFBR1 | 3.32827634 |
| 7 | TNIK | 3.13085496 |
| 8 | MAP2K3 | 2.96775378 |
| 9 | FLT3 | 2.85492266 |
| 10 | KIT | 2.75783137 |
| 11 | TGFBR2 | 2.62505769 |
| 12 | TESK2 | 2.55783312 |
| 13 | CDK19 | 2.39057710 |
| 14 | DYRK3 | 2.38363958 |
| 15 | TESK1 | 2.11884883 |
| 16 | BTK | 2.02102617 |
| 17 | MAP4K1 | 1.99661043 |
| 18 | MAP2K6 | 1.91868507 |
| 19 | JAK3 | 1.67065714 |
| 20 | EEF2K | 1.67005407 |
| 21 | BCKDK | 1.64826560 |
| 22 | TEC | 1.63487343 |
| 23 | WEE1 | 1.49826684 |
| 24 | ZAP70 | 1.44462602 |
| 25 | CAMKK2 | 1.43885206 |
| 26 | MAPKAPK5 | 1.40222490 |
| 27 | CSF1R | 1.34394410 |
| 28 | MATK | 1.30461670 |
| 29 | MAP3K6 | 1.29453383 |
| 30 | RPS6KB2 | 1.28010645 |
| 31 | PRKG2 | 1.27918677 |
| 32 | MAP2K7 | 1.25263195 |
| 33 | NLK | 1.24123634 |
| 34 | ABL2 | 1.20552309 |
| 35 | IRAK4 | 1.19478410 |
| 36 | MAP3K12 | 1.17646235 |
| 37 | GRK6 | 1.12464221 |
| 38 | SYK | 1.09473558 |
| 39 | NUAK1 | 1.09254333 |
| 40 | KDR | 1.04139650 |
| 41 | MKNK1 | 1.04099780 |
| 42 | HIPK2 | 1.03923233 |
| 43 | IKBKE | 1.03412214 |
| 44 | TBK1 | 1.02561070 |
| 45 | PKN2 | 1.02192415 |
| 46 | PASK | 1.01682010 |
| 47 | IKBKB | 0.96906208 |
| 48 | ADRBK2 | 0.96749171 |
| 49 | FES | 0.95537691 |
| 50 | CAMK1 | 0.94590545 |
| 51 | TXK | 0.94247160 |
| 52 | CDK8 | 0.92897728 |
| 53 | MAP2K4 | 0.90370813 |
| 54 | VRK2 | 0.89639252 |
| 55 | PIM2 | 0.86902273 |
| 56 | TYK2 | 0.85895059 |
| 57 | MYLK | 0.84893363 |
| 58 | SIK3 | 0.82525409 |
| 59 | CAMK1D | 0.79710553 |
| 60 | VRK1 | 0.79102579 |
| 61 | RIPK1 | 0.77282388 |
| 62 | LRRK2 | 0.74576493 |
| 63 | MAP4K2 | 0.73701558 |
| 64 | CCNB1 | 0.72159071 |
| 65 | LCK | 0.69060666 |
| 66 | LYN | 0.66399966 |
| 67 | MAPK4 | 0.65719100 |
| 68 | BLK | 0.64999140 |
| 69 | TAOK3 | 0.61598279 |
| 70 | ERN1 | 0.60902807 |
| 71 | MAPK15 | 0.60262791 |
| 72 | PRPF4B | 0.60254424 |
| 73 | MAPKAPK3 | 0.55219989 |
| 74 | NEK2 | 0.55172388 |
| 75 | MAP3K7 | 0.55024482 |
| 76 | RIPK4 | 0.54936796 |
| 77 | EPHB2 | 0.54785573 |
| 78 | DYRK1B | 0.53075985 |
| 79 | CDC7 | 0.51632462 |
| 80 | HCK | 0.50798653 |
| 81 | MAP2K2 | 0.50329326 |
| 82 | TAOK2 | 0.49354051 |
| 83 | PIK3CG | 0.49205980 |
| 84 | LIMK1 | 0.48025930 |
| 85 | BRSK2 | 0.47787282 |
| 86 | PIK3CA | 0.47242736 |
| 87 | MKNK2 | 0.46889251 |
| 88 | FER | 0.46388163 |
| 89 | MAPK13 | 0.45904079 |
| 90 | PAK4 | 0.45855057 |
| 91 | MAP3K11 | 0.45587353 |
| 92 | CDK7 | 0.45003655 |
| 93 | CSNK1G3 | 0.42265870 |
| 94 | ACVR1B | 0.41994371 |
| 95 | CAMK2D | 0.40246028 |
| 96 | ARAF | 0.39543902 |
| 97 | MAP3K13 | 0.39470401 |
| 98 | PRKCD | 0.39086991 |
| 99 | PRKD2 | 0.38869137 |
| 100 | GRK1 | 0.37767238 |
| 101 | CAMK2G | 0.36745519 |
| 102 | MAPK11 | 0.36596796 |
| 103 | RPS6KA4 | 0.36448765 |
| 104 | YES1 | 0.35473075 |
| 105 | PIM1 | 0.35308136 |
| 106 | CSNK1G1 | 0.34660471 |
| 107 | MAP3K1 | 0.34316448 |
| 108 | IRAK3 | 0.33024703 |
| 109 | ITK | 0.32463407 |
| 110 | TNK2 | 0.32420860 |
| 111 | ADRBK1 | 0.31954439 |
| 112 | BMPR2 | 0.31614221 |
| 113 | DAPK1 | 0.31606883 |
| 114 | PRKD1 | 0.30339549 |
| 115 | DAPK3 | 0.30200113 |
| 116 | RPS6KA6 | 0.29322665 |
| 117 | CDK9 | 0.28379196 |
| 118 | EIF2AK3 | 0.26689630 |
| 119 | RPS6KA5 | 0.26474587 |
| 120 | ATR | 0.25912838 |
| 121 | MAPK3 | 0.25785641 |
| 122 | PDK1 | 0.25781023 |
| 123 | PRKAA2 | 0.25011007 |
| 124 | GRK5 | 0.24967896 |
| 125 | PRKCQ | 0.24601559 |
| 126 | GRK7 | 0.24267728 |
| 127 | MAPKAPK2 | 0.23970557 |
| 128 | RPS6KL1 | 0.23769927 |
| 129 | RPS6KC1 | 0.23769927 |
| 130 | RET | 0.23265408 |
| 131 | DMPK | 0.23218383 |
| 132 | PRKCA | 0.21712243 |
| 133 | MAP3K5 | 0.21606630 |
| 134 | MAP3K14 | 0.19117672 |
| 135 | INSRR | 0.18096612 |
| 136 | SRC | 0.17150992 |
| 137 | RPS6KA2 | 0.15797030 |
| 138 | CHEK2 | 0.15608729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.96473434 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.64833195 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.03633983 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.02498258 |
| 5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.81024870 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.71464008 |
| 7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.53860756 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.53433160 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.36868770 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.26557990 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.22162626 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.16331503 |
| 13 | Platelet activation_Homo sapiens_hsa04611 | 2.15242208 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 2.04581740 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 2.00408006 |
| 16 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.96660088 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.93605708 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.90516680 |
| 19 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.88320152 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87733820 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87138225 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.83348595 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.76479277 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.76244424 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.75299574 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.69631977 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58125275 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.55900137 |
| 29 | RNA polymerase_Homo sapiens_hsa03020 | 1.55624674 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.53535017 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50677368 |
| 32 | Spliceosome_Homo sapiens_hsa03040 | 1.48291533 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.43908045 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42047001 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.40405037 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39962412 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39047817 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.38174460 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.37534271 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.37337601 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.37205682 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36484751 |
| 43 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.31490041 |
| 44 | Measles_Homo sapiens_hsa05162 | 1.28731262 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.26841449 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.26298588 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 1.24703482 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24149421 |
| 49 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.23876895 |
| 50 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.22974622 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 1.22611596 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 1.22329636 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.21138374 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.18188304 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.17005143 |
| 56 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.15602771 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14047693 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.13102627 |
| 59 | Thyroid cancer_Homo sapiens_hsa05216 | 1.12820648 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.11455260 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.08896447 |
| 62 | Purine metabolism_Homo sapiens_hsa00230 | 1.06201151 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05936023 |
| 64 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.05371926 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.03906189 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03848336 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03623211 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.02939857 |
| 69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.02095121 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00019720 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.98370572 |
| 72 | Influenza A_Homo sapiens_hsa05164 | 0.94855763 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92774017 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.92050716 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91642521 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88796855 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87859944 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84424835 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.82814549 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.82111357 |
| 81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81638311 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.81022794 |
| 83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80859340 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78983538 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.77484683 |
| 86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74201994 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73449008 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72628433 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71085954 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70785712 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68710416 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68622625 |
| 93 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.65984004 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65884032 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65478253 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64618983 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.64518320 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63917598 |
| 99 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63276721 |
| 100 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63061813 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.63037969 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62916716 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62336765 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62308374 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.61438426 |
| 106 | Cell cycle_Homo sapiens_hsa04110 | 0.60644376 |
| 107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60641848 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59835902 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59705198 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59243605 |
| 111 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58958064 |
| 112 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.58184149 |
| 113 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.57761544 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.57492404 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56631229 |
| 116 | Renin secretion_Homo sapiens_hsa04924 | 0.56388365 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56333838 |
| 118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54690571 |
| 119 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.54103638 |
| 120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52854859 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.50827774 |
| 122 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50783119 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50099637 |
| 124 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48618233 |
| 125 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45424560 |
| 126 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44783431 |
| 127 | RNA transport_Homo sapiens_hsa03013 | 0.44350977 |
| 128 | Salivary secretion_Homo sapiens_hsa04970 | 0.43235818 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42845676 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41643202 |
| 131 | Apoptosis_Homo sapiens_hsa04210 | 0.40510127 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40504691 |
| 133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40441666 |
| 134 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39149444 |
| 135 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37713272 |
| 136 | Pathways in cancer_Homo sapiens_hsa05200 | 0.36445277 |
| 137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36205021 |
| 138 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34275753 |
| 139 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.31389713 |
| 140 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30754388 |
| 141 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.29254500 |
| 142 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28893153 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28347754 |
| 144 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.27945582 |
| 145 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26392293 |
| 146 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.26171689 |
| 147 | Tuberculosis_Homo sapiens_hsa05152 | 0.25378171 |
| 148 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23078418 |
| 149 | Allograft rejection_Homo sapiens_hsa05330 | 0.22479474 |
| 150 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.20268440 |

